Generation Bio Co (NASDAQ:GBIO) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Charles A Rowland Jr Other companies: Viking Therapeutics, Inc. (Director · Since at least Jul 1, 2017); Orchard Therapeutics PLC (Director · Jan 1, 2020 – Jan 24, 2024 · Past); Nabriva Therapeutics AG (Director · Dec 30, 2016 – Aug 3, 2022 · Past); Blueprint Medicines Corp (Director · Apr 30, 2015 – Jun 2, 2021 · Past); Vitae Pharmaceuticals Inc (Director · Sep 24, 2014 – Oct 25, 2016 · Past); BIND Therapeutics Inc (Director · May 28, 2014 – Jun 21, 2016 · Past); Idenix Pharmaceuticals Inc (Director · Jun 6, 2013 – Aug 5, 2014 · Past); Viropharma Inc (VP, Chief Financial Officer · Oct 20, 2008 – Jan 24, 2014 · Past) | Director · Since at least Jun 11, 2020 |
| Stephen J DiPalma Other companies: Inozyme Pharma Inc (Interim CFO · May 17, 2021 – May 17, 2021 · Past); Solid Biosciences Inc. (Interim CFO · Jan 29, 2021 – Jan 29, 2021 · Past); Chemomab Therapeutics Ltd. (Chief Financial Officer · May 1, 2020 – May 1, 2020 · Past); Spero Therapeutics, Inc. (See Remarks · Nov 8, 2019 – Jul 15, 2023 · Past); Interleukin Genetics Inc (Interim CFO · Jul 29, 2016 – Jul 29, 2016 · Past) | See Remarks · Jun 11, 2020 – Jun 11, 2020 · Past |
| Jason Rhodes Other companies: Dyne Therapeutics, Inc. (Chairman · Since at least Sep 16, 2020); Disc Medicine, Inc. (Director · Feb 5, 2021 – Oct 4, 2021 · Past); Replimune Group, Inc. (Director · Jul 19, 2018 – Apr 1, 2022 · Past); Epizyme Inc (President, CFO and Treasurer · May 30, 2013 – Sep 22, 2014 · Past) | Director · Since at least Jun 11, 2020 |
| Jeffrey M Jonas Other companies: COMPASS Pathways Plc (Director · Since at least Oct 29, 2025); Karuna Therapeutics Inc (Director · Jun 27, 2019 – Mar 15, 2024 · Past); Sage Therapeutics Inc (Director · May 23, 2019 – Jun 10, 2024 · Past) | Director · Since at least Jun 11, 2020 |
| Donald William Nicholson Other companies: Disc Medicine, Inc. (Director · Since at least Dec 29, 2022); Kymera Therapeutics, Inc. (Director · Jun 16, 2021 – Jun 15, 2022 · Past) | Director · Since at least Jan 11, 2021 |
| Geoff McDonough Other companies: Third Harmonic Bio Inc. (Director · Mar 27, 2024 – Mar 27, 2024 · Past); Surface Oncology Inc (Director · Jun 5, 2019 – Jun 8, 2021 · Past) | Director · Since at least Jun 11, 2020 |
| Gustav Christensen Other companies: Morphic Holding Inc (Director · Jun 26, 2019 – Aug 16, 2024 · Past); Dyax Corp (CEO and President, Director · Apr 26, 2007 – Jan 14, 2016 · Past) | Director · Since at least Jun 11, 2020 |
| Douglas Kerr Other companies: Dyne Therapeutics, Inc. (Head of R&D and CMO · Since at least Sep 3, 2024) | CHIEF MEDICAL OFFICER · Jun 11, 2020 – Jan 29, 2024 · Past |
| Matthew Norkunas Other companies: Obsidian Therapeutics, Inc. (Director · Since at least Aug 3, 2026) | CHIEF FINANCIAL OFFICER · Jan 22, 2021 – Jan 10, 2025 · Past |
| Yalonda Howze Other companies: Codiak BioSciences Inc (See Remarks · Jul 2, 2020 – Mar 30, 2023 · Past) | INTERIM CEO AND PRESIDENT · Since at least Apr 5, 2023 |
| Anthony G Quinn | Director · Since at least Jun 4, 2025 |
| Mark D Angelino | CHIEF OPERATING OFFICER · Jun 11, 2020 – Feb 5, 2021 · Past |
| Matthew Stanton | CHIEF SCIENTIFIC OFFICER · Jun 11, 2020 – Jan 10, 2025 · Past |
| Phillip Samayoa | CHIEF SCIENTIFIC OFFICER · Since at least Sep 16, 2022 |
| Tracy Zimmermann | CHIEF DEVELOPMENT OFFICER · Nov 9, 2020 – Jan 29, 2024 · Past |